Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients

Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients

Background: Atrial fibrillation (AF) is the most frequent tachyarrhythmia in patients with a permanent pacemaker. Angiotensin II receptor antagonists have a protective effect against the occurrence of AF in patients with heart diseases. This study aimed to assess the effectiveness of olmesartan in t...

Full description

Bibliographic Details
Main Authors: Hang Zhang, Chang Pan, Juan Zhang, Lin-Lin Zhu, Kai Huang, Yun Zhong, Zuo-Ying Hu
Format: Article
Language:English
Published: Wolters Kluwer 2016-01-01
Series:Chinese Medical Journal
Subjects:
Angiotensin II Receptor Antagonist; Atrial Fibrillation; Olmesartan; Pacemaker; Ventricular Pacing
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=18;spage=2143;epage=2148;aulast=Zhang

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=18;spage=2143;epage=2148;aulast=Zhang

Similar Items